Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Moodys
McKesson
Express Scripts
Medtronic

Last Updated: August 14, 2022

AJOVY Drug Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Recent Litigation for AJOVY

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company2018-09-27

See all AJOVY litigation

PTAB Litigation
PetitionerDate
Eli Lilly and Company2018-09-28

See all AJOVY litigation

Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

  1. Brand-side disclosures in response to biosimilar applications
  2. These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

  3. General brand-side disclosures
  4. These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

  5. Patents from broad patent text search
  6. For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for AJOVY Derived from Brand-Side Litigation

No patents found based on brand-side litigation

2) High Certainty: US Patents for AJOVY Derived from Company Disclosures

These patents were obtained from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Patent No. Estimated Patent Expiration Source
Teva Branded Pharmaceutical Products R&d, Inc. AJOVY fremanezumab-vfrm Injection 761089 See Plans and Pricing 2025-11-14 Company disclosures
Teva Branded Pharmaceutical Products R&d, Inc. AJOVY fremanezumab-vfrm Injection 761089 See Plans and Pricing 2025-11-14 Company disclosures
Teva Branded Pharmaceutical Products R&d, Inc. AJOVY fremanezumab-vfrm Injection 761089 See Plans and Pricing 2034-03-21 Company disclosures
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Patent No. >Estimated Patent Expiration >Source

3) Low Certainty: US Patents for AJOVY Derived from Patent Text Search

No patents found based on company disclosures

Supplementary Protection Certificates for AJOVY

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
PA2019015,C2380592 Lithuania See Plans and Pricing PRODUCT NAME: FREMANEZUMABAS; REGISTRATION NO/DATE: EU/1/19/1358 20190328
300988 Netherlands See Plans and Pricing PRODUCT NAME: GALCANEZUMAB; REGISTRATION NO/DATE: EU/1/18/1330 20181116
2019C/521 Belgium See Plans and Pricing PRODUCT NAME: FREMANEZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/19/1358 20190401
689 Finland See Plans and Pricing
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Mallinckrodt
Boehringer Ingelheim
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.